US Patent Issued to ABL Bio on May 12 for "Antibody to insulin-like growth factor 1 receptor (IGF1R) and related compositions and uses" (South Korean Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,110, issued on May 12, was assigned to ABL Bio Inc. (Seongnam-si, South Korea).

"Antibody to insulin-like growth factor 1 receptor (IGF1R) and related compositions and uses" was invented by Jinhyung Ahn (Seongnam-si, South Korea), Sungwon An (Seongnam-si, South Korea), Dongin Kim (Seongnam-si, South Korea), Eunsil Sung (Seongnam-si, South Korea), Jaehyun Eom (Seongnam-si, South Korea), Sang Hoon Lee (Seongnam-si, South Korea), Weonkyoo You (Seongnam-si, South Korea), Juhee Kim (Seongnam-si, South Korea), Kyungjin Park (Seongnam-si, South Korea), Hyejin Chung (Seongnam-si, South Korea), Jinwon Jung (Seongnam-si, South Korea), Bora Lee (Seongnam-si, South Korea), Byungje Sung (Seongn...